Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

AAM. 2019; 8(3-4): 114-125


Clinical study to evaluate role of Ayurvedic Virechana (therapeutic purgation) and oral Phala Ghrita intake in the management of oligozoospermia

jitendra varsakiya,Mandip Goyal,Anup Thakar,Shilpa Donga,Divyarani kathad.




Abstract

Background: Parenthood is one most desired goal of every couple, and failure to procreate causes great anguish. Infertility is a social stigma at many places in India dominated by illiteracy and lower socio-economic standards. It affects the psychological harmony, marital life and social functioning of those affected. Infertility is the inability of a sexually active, non-contracepting couple to achieve spontaneous pregnancy in 1 year. Shodhana(bio-purification) is recommended in such cases to enhance the effects of ayurvedic anti infertility therapy ( vajikarana ). Virechana( therapeutic purgation) is largely indicated for cases having a semen abnormality ( shukra dushti) . Phala Ghrita ( PG) is a poly herbal formulation
reported to be useful in improving fertility.. Aim: This study aimed to evaluate efficacy of Phala Ghrita oral administration after performing a course of virechana in cases of oligozoospermia. Materials and Methods: 51 eligible male participants between the age of 21 and 40 years, with sperm count

Key words: Ksheena Shukra, oligozoospermia, Phala Ghrita , Virechana






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.